VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Lags Revenue Estimates

VYNE Therapeutics Inc. (VYNE) delivered earnings and revenue surprises of -5.88% and -12.51%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for…